Injectable formulations of PARP inhibitors and uses thereof
US12383633B1 · kind B1 · utility
0Cited by
5References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2024 |
| Grant date | Aug 12, 2025 |
| Priority date | — |
| Expiry date | Oct 1, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are injectable or infusible formulations of PARP inhibitors. In one aspect, the formulation comprises a PARP inhibitor and a cyclodextrin. The injectable or infusible PARP inhibitor-cyclodextrin formulation improves drug solubility, bioavailability, and therapeutic effectiveness. Also described herein are methods for treating oncological and non-oncological indications with injectable or infusible formulations of PARP inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.